The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I expansion study of sunitinib and bevacizumab in patients with advanced solid malignancies.
Kriti Mittal
No relevant relationships to disclose
Henry B. Koon
No relevant relationships to disclose
Paul Elson
No relevant relationships to disclose
Pierre L. Triozzi
No relevant relationships to disclose
Afshin Dowlati
No relevant relationships to disclose
Ernest C. Borden
No relevant relationships to disclose
Brian I. Rini
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer